Watch Ticker

Harmony Biosciences Holdings, Inc. Common Stock

Go to Harmony Biosciences Holdings, Inc. Common Stock Website

$34.15

-1.39 (-3.93%)

Live

Previous Close

$35.54

Day Range

$32.64 - $34.85

Previous Day Range

$34.38 - $35.59

Market Cap

$2.0 billion USD

Day Vol.

594354

Previous Day Vol.

673290

Currency

USD

Primary Exchange

Nasdaq

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisan...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight

The Developmental and Epileptic Encephalopathies (DEE) market is expected to grow significantly due to approved medications like EPIDIOLEX, rising demand for novel treatments, and the introduction of potential emerging therapies. However, the discontinuation of emerging therapies may impede this growth.

Related tickers: TAK, ESAIY, HLBAY, HRMY.

Read Full Article

Delveinsight - 5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The 5-HT2 agonist pipeline is robust, with over 20 pharmaceutical companies actively developing 22+ pipeline drugs. Advancements in precision medicine and personalized approaches are driving the market, enabling selective targeting of receptor subtypes and improving safety and efficacy.

Related tickers: CYBN, HRMY, MNMD, ATAI, RVPH, RVPHW.

Read Full Article

Trending Tickers

Please sign in to view